IN THE first post-merger AGM yesterday, Sigma Chairman Michael Sammells reminded shareholders of the merits of the merger in combining the logistics and warehousing expertise of Sigma and the retail and marketing expertise of Chemist Warehouse.
"It has only been 252 days since our merger was completed, and the reality since merger is that it has so far delivered everything we anticipated and more," he said.
Key highlights were the 400% growth in Sigma's share price over the last two years, with the group's current market value of around $35 billion placing it in the top 20 companies on the ASX.
The company's net debt, forecast pre-merger to be around $1 to $1.3 billion, was only $752 million, thanks to "strong operational performance and cash flow generation".
CEO Vikesh Ramsunder outlined some of the year's financial highlights as described in the FY25 ASX statement (PD 27 Aug), while pointing to strong indicators in the first quarter of FY26.
"Looking ahead, we have a positive long-term outlook, and our execution priorities are clear," Ramsunder said.
These include opening new stores domestically and internationally, particularly in under-penetrated local and offshore markets; revitalising Amcal and DDS; and rolling out own and exclusive products while remaining "a house of brands".
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Oct 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Oct 25
